◆ Market Data --:--
Commodities
Loading...
📈 Yields & Rates
Loading...
💱 FX Rates
Loading...
📈 Market Pulse
Loading...
🏛 Congress Trades
Loading...
👤 Insider Trades
Loading...
Customize Items
HISAMITSU PHARMACEUTICAL CO.,INC. — Financial Statements
5 10 All
Income Statement
Balance Sheet
Cash Flow
Line ItemQ4 2025Oct 10, 2025Q1 2025Feb 28, 2025Q4 2024Oct 11, 2024Q1 2024Feb 29, 2024Q1 2023Feb 28, 2023Q1 2022Feb 28, 2022Q1 2021Feb 28, 2021
+Operating Income 9.0B -- 8.4B -- -- -- --
Operating Margin % 83.5% -- 72.1% -- -- -- --
+Ordinary Income 10.8B -- 11.6B -- -- -- --
Revenue Growth % -- -- -- -- -- -- --
Line ItemQ4 2025Oct 10, 2025Q1 2025Feb 28, 2025Q4 2024Oct 11, 2024Q1 2024Feb 29, 2024Q1 2023Feb 28, 2023Q1 2022Feb 28, 2022Q1 2021Feb 28, 2021
Current Assets 203.8B -- 194.0B -- -- -- --
Total Assets 343.1B 338.8B 328.8B 334.9B 336.9B 309.6B 296.5B
Current Liabilities 47.2B -- 45.9B -- -- -- --
Total Liabilities 63.7B 72.0B 61.7B 63.4B 65.1B 49.0B 45.8B
Total Equity 279.4B 266.9B 267.1B 271.5B 271.8B 260.5B 250.7B
Equity Ratio -- 0.78 -- 0.80 0.80 0.84 0.84
No data available for this statement.
NEWS
Loading article...
NEWS
Loading news...
TRENDING
Loading...